Pleural Effusions in Patients With Hodgkin Lymphoma: Clinical Predictors and Associations With Outcome

• DOI: 10.1016/j.ijrobp.2012.07.1635
• Publication Date: 2012-10-25T21:04:26Z
• Authors: B. Hunter; S. Dhakal; S. Voci; N. Goldstein; L.S. Constine
• Keywords: Male; Incidence; Prognosis; Hodgkin Disease; Pleural Effusion, Malignant; 3. Good health; 03 medical and health sciences; 0302 clinical medicine; Positron-Emission Tomography; Odds Ratio; Humans; Female; Tomography, X-Ray Computed; Neoplasm Staging

Pleural effusions are common in Hodgkin lymphoma (HL). However, little is known about their prognostic significance. One hundred and ten patients with HL who presented to the University of Rochester from 1 January 2003 to 12 December 2010 were reviewed. Pleural effusions were evaluated on review of diagnostic-quality computed tomography (CT) scans. Pleural effusions were present in 26/110 patients: 1/7 (14%) stage I, 11/61 (18%) stage II, 3/18 (17%) stage III and 11/24 (46%) stage IV, and 25/91 (27%) patients had mediastinal involvement, 16/38 (42%) patients had extranodal involvement (any) and 5/14 (35%) patients had E lesions (direct extension to extranodal tissue). Unilateral and bilateral pleural effusions were equally prevalent. Survival analysis demonstrated decreased overall survival for patients with pleural effusions of borderline significance for stage I-IV (p = 0.055) but failed to show significance for patients with stage I-III (p = 0.115). Increasing stage, any extranodal involvement and bulky mediastinal disease were each predictive of pleural effusions. The presence of pleural effusion at presentation may be predictive of inferior survival for patients with Hodgkin lymphoma.